首页|期刊导航|中华医学杂志（英文版）|Advances in targeted therapy and immunotherapy for esophageal cancer

Advances in targeted therapy and immunotherapy for esophageal cancer

Haiou Yang Xuewei Li Wenhui Yang

中华医学杂志（英文版）2023，Vol.136Issue(16)：1910-1922,13.

中华医学杂志（英文版）2023，Vol.136Issue(16)：1910-1922,13.DOI:10.1097/CM9.0000000000002768

Advances in targeted therapy and immunotherapy for esophageal cancer

Haiou Yang ¹Xuewei Li ²Wenhui Yang³

作者信息

1. Cancer center,Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital,Third Hospital of Shanxi Medical University,Taiyuan,Shanxi 030032,China
2. Department of Biochemistry and Molecular Biology,Shanxi Key Laboratory of Birth Defect and Cell Regeneration,Shanxi Medical University,Taiyuan,Shanxi 030001,China
3. Department of Gastroenterology,Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University,Taiyuan,Shanxi 030001,China
折叠

摘要

关键词

Esophageal cancer/Targeted therapy/Immunotherapy/Epidermal growth factor receptor/Vascular endothelial growth factor/Programed cell death ligand 1/Programed death-1/Cytotoxic T lymphocyte-associated antigen-4

Key words

引用本文复制引用

Haiou Yang,Xuewei Li,Wenhui Yang..Advances in targeted therapy and immunotherapy for esophageal cancer[J].中华医学杂志（英文版）,2023,136(16):1910-1922,13.

基金项目

This study was supported by grants from the National Natural Science Foundation of China(No.82002619),the Key Medical Research Projects of Shanxi Province(No.2020XM55),the Talent Introduction Scientific Re-search Start-up Fund of Shanxi Bethune Hospital(No.2020RC006),the special fund for Science and Technol-ogy Innovation Teams of Shanxi Province(No.202204051001031),and Fundamental Research Pro-gram of Shanxi Province(No.202203021222349). （No.82002619）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINE

ISSN：0366-6999

访问量0

下载量0

段落导航